Based on management commentary during recent earnings calls, companies that are likely to be active in M&A this year include Johnson & Johnson, Hologic, Boston Scientific (although not to the extent it was in 2021), and possibly Abbott.
On Friday, Ryan Zimmerman, a medtech analyst at BTIG, pointed to seven medical device subsectors that could be attractive from an M&A perspective. In the following slides, we take a look at each of those spaces and offer our own educated guesses as to some of the players that could potentially be scooped up by a larger company this year.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,